Bioxytran (BIXT) Earnings Date, Estimates & Call Transcripts → Breaking News: Elon Musk Invents New Type of A.I. (Shocking) (From InvestorPlace) (Ad) Free BIXT Stock Alerts $0.13 0.00 (0.00%) (As of 05/17/2024 ET) Add Compare Share Share EarningsStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Earnings SummaryLatest Earnings DateMar. 22EstimatedActual EPS (Mar. 22) -$0.01 Missed By -$0.01 Get Bioxytran Earnings AlertsEnter your email address below to receive the latest news and earnings results for BIXT and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueBIXT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.BIXT Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad InvestorPlaceBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… BIXT Earnings Date and InformationBioxytran last issued its quarterly earnings results on March 22nd, 2024. The reported ($0.01) earnings per share (EPS) for the quarter. Bioxytran has generated ($0.03) earnings per share over the last year (($0.03) diluted earnings per share). Read More Bioxytran Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript3/22/2024Q4 2023-($0.01)($0.01)($0.01)--11/2/2023Q3 2023-($0.01)($0.01)($0.01)--7/31/2023Q2 2023-($0.01)($0.01)($0.01)--5/12/2023Q1 2023-($0.01)($0.01)($0.01)--8/15/2022Q2 2022-($0.01)($0.01)($0.01)--5/23/2022Q1 2022-($0.01)($0.01)($0.01)-- Get the Latest News and Ratings for BIXT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bioxytran and its competitors with MarketBeat's FREE daily newsletter. 4/11/2022Q4 2021-($0.01)($0.01)($0.01)--8/10/2021Q2 2021-($0.01)($0.01)($0.01)-- Bioxytran Earnings - Frequently Asked Questions When did Bioxytran announce their last quarterly earnings? Bioxytran (OTCMKTS:BIXT) last announced its quarterly earning data on Friday, March 22, 2024. Learn more on BIXT's earnings history. How much profit does Bioxytran generate each year? Bioxytran (OTCMKTS:BIXT) has a recorded net income of -$4.28 million. BIXT has generated -$0.03 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: Benitec Biopharma Earnings Cumberland Pharmaceuticals Earnings MEI Pharma Earnings Bullfrog AI Earnings Orgenesis Earnings Lumos Pharma Earnings Alaunos Therapeutics Earnings TherapeuticsMD Earnings Synlogic Earnings Inhibitor Therapeutics Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Baidu Stock Earnings Prove Ray Dalio Right about China?Home Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution This page (OTCMKTS:BIXT) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceMost important medical advance in 100 yearsThe Oxford ClubMissed NVDA? Buy this AI stock NOWChaikin AnalyticsHe Is Giving Away BitcoinCrypto Swap ProfitsBiden Nomination CANCELED?The Freeport SocietyGuard Against the Coming Financial UpheavalPorter & Company4 Cryptos BETTER than BitcoinTrue Market InsidersProtect Your Bank Account Before It’s Too LateWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bioxytran, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
